A horse or a zebra? Unusual manifestations of common cutaneous infections in primary immunodeficiency pediatric patients

被引:1
作者
Ollech, Ayelet [1 ,2 ]
Simon, Amos J. [2 ,3 ,4 ,5 ,6 ]
Lev, Atar [3 ,4 ]
Stauber, Tali [2 ,3 ,4 ]
Sherman, Gilad [2 ,7 ]
Solomon, Michal [2 ,8 ]
Barzilai, Aviv [2 ,8 ]
Somech, Raz [2 ,3 ,4 ,5 ,6 ]
Greenberger, Shoshana [1 ,2 ]
机构
[1] Sheba Med Ctr, Dept Dermatol, Pediat Dermatol Serv, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[3] Sheba Med Ctr, Sheba Canc Res Ctr, Ramat Gan, Israel
[4] Sheba Med Ctr, Inst Hematol, Ramat Gan, Israel
[5] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Jeffrey Modell Fdn Ctr, Pediat Dept A, Ramat Gan, Israel
[6] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Jeffrey Modell Fdn Ctr, Immunol Serv, Ramat Gan, Israel
[7] Sheba Med Ctr, Edmond & Lily Safra Childrens Hosp, Pediat Infect Dis Unit, Ramat Gan, Israel
[8] Sheba Med Ctr, Dept Dermatol, Ramat Gan, Israel
来源
FRONTIERS IN PEDIATRICS | 2023年 / 11卷
关键词
immunological aspects; cutaneous; infection; inborn error of immunity; pediatric; primary immunodeficiencies; STEM-CELL TRANSPLANTATION; HUMAN-PAPILLOMAVIRUS; DEFICIENCY; DISEASE; INPATIENT;
D O I
10.3389/fped.2023.1103726
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BackgroundPatients with primary immunodeficiency disorders (PIDs) often suffer from recurrent infections because of their inappropriate immune response to both common and less common pathogens. These patients may present with unique and severe cutaneous infectious manifestations that are not common in healthy individuals and may be more challenging to diagnose and treat.ObjectiveTo describe a cohort of patients with PIDs with atypical presentations of skin infections, who posed a diagnostic and/or therapeutic challenge.MethodsThis is a retrospective study of pediatric patients with PID with atypical presentations of infections, who were treated at the immunodeficiency specialty clinic and the pediatric dermatology clinic at the Sheba Medical Center between September 2012 and August 2022. Epidemiologic data, PID diagnosis, infectious etiology, presentation, course, and treatment were recorded.ResultsEight children with a diagnosis of PID were included, five of whom were boys. The average age at PID diagnosis was 1.7 (+/- SD 3.2) years. The average age of cutaneous infection was 6.9 (+/- SD 5.9) years. Three patients were born to consanguineous parents. The PIDs included the following: common variable immunodeficiency, severe combined immunodeficiency, DOCK8 deficiency, ataxia telangiectasia, CARD11 deficiency, MALT1 deficiency, chronic granulomatous disease, and a combined cellular and humoral immunodeficiency syndrome of unknown etiology. The infections included the following: ulcerative-hemorrhagic varicella-zoster virus (two cases) atypical fungal and bacterial infections, resistant Norwegian scabies, giant perianal verrucae (two cases), and diffuse molluscum contagiosum.ConclusionsIn this case series, we present unusual manifestations of infectious skin diseases in pediatric patients with PID. In some of the cases, recognition of the infectious process prompted life-saving treatment. Increasing familiarity with these dermatological manifestations, as well as keeping a high index of suspicion, is important to enabling early diagnosis of cutaneous infections in PIDs and initiation of prompt suitable treatment.
引用
收藏
页数:10
相关论文
共 47 条
  • [21] Immunological Characteristics and Two Novel Mutations in TACI in a Cohort of 28 Pediatric Patients with Common Variable Immunodeficiency
    Almejun, Maria B.
    Sajaroff, Elisa
    Galicchio, Miguel
    Oleastro, Matias
    Bernasconi, Andrea
    Zelazko, Marta
    Danielian, Silvia
    JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 (01) : 89 - 97
  • [22] Clinical and immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications
    Aydogan, M.
    Eifan, A. O.
    Gocmen, I.
    Ozdemir, C.
    Bahceciler, N. N.
    Barlan, I. B.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2008, 18 (04) : 260 - 265
  • [23] Individualized immunoglobulin treatment in pediatric patients with primary humoral immunodeficiency disease
    Patel, Niraj C.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (06) : 583 - 588
  • [24] Subcutaneous immunoglobulin 16.5% for the treatment of pediatric patients with primary antibody immunodeficiency
    Gupta, Sudhir
    Kobayashi, Roger H.
    Litzman, Jiri
    Cherwin, Laurel
    Hoeller, Sonja
    Kreuwel, Huub
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (01) : 7 - 17
  • [25] Pulmonary function evaluation in pediatric patients with primary immunodeficiency complicated by bronchiectasis
    Chiu, Chun-Che
    Wang, Chao-Jan
    Lee, Wen-I.
    Wong, Kin-Sun
    Chiu, Chih-Yung
    Lai, Shen-Hao
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (06) : 1014 - 1020
  • [26] Endoscopic and histopathological hints on infections in patients of common variable immunodeficiency disorder with gastrointestinal symptoms
    Yang Chen
    Yan You
    Ji Li
    Aiming Yang
    Weixun Zhou
    Xiaoqing Li
    BMC Gastroenterology, 23
  • [27] Autoimmune and inflammatory manifestations in pediatric patients with primary immunodeficiencies and their importance as a warning sign
    Kaplan, M. Yildirim
    Ozen, S.
    Akcal, O.
    Gulez, N.
    Genel, F.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2020, 48 (06) : 701 - 710
  • [28] Cutaneous granulomas with primary immunodeficiency in children: a report of 17 new patients and a review of the literature
    Leclerc-Mercier, S.
    Moshous, D.
    Neven, B.
    Mahlaoui, N.
    Martin, L.
    Pellier, I.
    Blanche, S.
    Picard, C.
    Fischer, A.
    Perot, P.
    Eloit, M.
    Fraitag, S.
    Bodemer, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (07) : 1412 - 1420
  • [29] Population Pharmacokinetics of Intravenous Busulfan in Japanese Pediatric Patients With Primary Immunodeficiency Diseases
    Ishiwata, Yasuyoshi
    Nagata, Masashi
    Tsuge, Kohta
    Takahashi, Hiromitsu
    Suzuki, Sayo
    Imai, Kohsuke
    Takagi, Masatoshi
    Kanegane, Hirokazu
    Morio, Tomohiro
    Yasuhara, Masato
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (03) : 327 - 331
  • [30] Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases
    Baumann, Ulrich
    Fasshauer, Maria
    Pausch, Christine
    Wittkowski, Helmut
    Hermann, Corinna
    Pittrow, David
    Borte, Michael
    IMMUNOTHERAPY, 2022, 14 (02) : 135 - 143